Comments on: Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

Comments on: Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older https://insideout.vn/vaxcyte-to-host-webcast-and-conference-call-to-present-topline-results-from-phase-1-2-study-of-vax-31-its-31-valent-pneumococcal-conjugate-vaccine-candidate-in-adults-aged-50-and-older/ Inside Out Tue, 03 Sep 2024 04:59:33 +0000 hourly 1 https://wordpress.org/?v=6.6.2